Skip to main content
. 2020 Jul 14;30(12):6818–6827. doi: 10.1007/s00330-020-07050-x

Table 3.

CT diagnostic accuracy

Highly suggestive CT findings
TP FP TN FN

Sensitivity

(95% CI)

Specificity

(95% CI)

PPV

(95% CI)

NPV

(95% CI)

Reference standard 1

Prevalence 79.2%

423 31 114 128

76.77%

(73.0–80.2%)

78.62%

(71.0–85.0%)

93.17%

(90.4–95.3%)

47.11%

(40.7–53.6%)

Reference standard 2

Prevalence 80.9%

428 26 107 135

76.02%

(72.3–79.5%)

80.45%

(72.7–86.8%)

94.27%

(91.7–96.2%)

44.21%

(37.9–50.7%)

Reference standard 3

Prevalence 85.6%

438 16 84 158

73.49%

(69.8–77.0%)

84.00%

(75.3–90.6%)

96.48%

(94.3–98.0%)

34.71%

(28.7–41.1%)

Highly suggestive + suggestive CT findings
TP FP TN FN

Sensitivity

(95% CI)

Specificity

(95% CI)

PPV

(95% CI)

NPV

(95% CI)

Reference standard 1

Prevalence 79.2%

520 61 84 31

94.37%

(92.1–96.1%)

57.93%

(49.5–66.1%)

89.50%

(86.7–91.9%)

73.04%

(64.0–80.9%)

Reference standard 2

Prevalence 80.9%

526 55 78 37

93.43%

(91.1–95.3%)

58.65%

(49.8–67.1%)

90.53%

(87.9–92.8%)

67.83%

(58.5–76.2%)

Reference standard 3

Prevalence 85.6%

539 42 58 57

90.44%

(87.8–92.7%)

58.0%

(47.7–67.8%)

92.77%

(90.4–94.7%)

50.43%

(41.0–59.9%)

Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) with respective 95% confidence intervals (CI) for two levels of CT-based probability of COVID-19 pneumonia (highly suggestive only and highly suggestive plus suggestive findings), and for three reference standards: (1) the first RT-PCR; (2) plus repeated RT-PCR tests (within 15 days) in patients with negative first RT-PCR; if RT-PCR was not repeated the patient was considered negative; (3) as in the second scenario, but negative patients who were not retested with RT-PCR were classified as positive or negative in the same proportion of patients who were actually retested in each group of CT-based probability of COVID-19